New device could let surgeons see tissues in real time during gynecological surgery
NCT ID NCT04154683
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tests Cellvizio, a device that provides real-time, high-resolution views of tissues during gynecological surgery. Researchers want to see if it can help diagnose lesions and check surgical margins more accurately. The study will enroll 80 women undergoing laparoscopic surgery for conditions like endometriosis or cancer. Results will be compared with standard pathology reports.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Cellvizio optical biopsy device
- What this could lead to
- If successful, this could make diagnosis during gynecological surgery faster and more accurate, reducing the need for traditional biopsies.
- What could go wrong
- This is a small, early-stage study with only 80 participants, so results may not apply to all patients. The technology may not match standard pathology in accuracy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Gynaecology Department, Hôpital Femme Mère Enfant Hospices Civisl de Lyon
NOT_YET_RECRUITINGBron, 69500, France
-
Service de Gynécologie, HFME, Hospices Civils de Lyon
RECRUITINGBron, 69500, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Can an antiviral make radiation more effective against cervical cancer?
- What raises endometrial cancer risk in black women? a study digs in
- A One-Two punch against cervical cancer: testing plus vaccination in HIV-Positive women
- Can a Two-Antibody combo outsmart advanced cancer?
- Can immunotherapy plus hormones spare the womb in early endometrial cancer?